CYCatherine H. Yu

Catherine H. Yu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Catherine H. Yu has a total of 202 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluating the Methodological Quality of Artificial Intelligence–Assisted Systematic Reviews: Protocol for a Mixed Methods Meta-Research Study

    by Mohammad Jay, Mary Morgan, Sharon Elizabeth Straus, Emma Wilson, Rinku Sutradhar, Catherine Yu, Lesley Gotlib Conn, Christoffer Dharma, Lorraine Lipscombe, Antoine Eskander

    Background: Artificial intelligence (AI), including large language models (LLMs), is increasingly integrated into systematic review (SR) workflows. AI tools may accelerate searching, screening, data extraction, and reporting, but their effects on methodological quality, reporting completeness, transparency, and reproducibility remain uncertain. Existing evaluations largely examine isolated tasks, and inconsistent disclosure of AI use limits reproducibility and oversight. Objective: This 4-phase mixed methods meta-research study will (1) compare the methodological quality of AI-assisted versus traditional SRs; (2) refine, finalize, and apply a preliminary AI Transparency and Disclosure Index (AITDI); (3) evaluate reproducibility by comparing outputs across repeated runs of the same AI model, across different AI models, and between AI models and human reviewers at multiple SR stages; and (4) explore knowledge user perspectives on rigor, transparency, and trust in AI-assisted SRs. Methods: We will conduct a matched cohort analysis of SRs published from 2023 to 2025 in biomedical journals. Each AI-assisted SR will be matched 1:2 with traditional SRs by publication year, clinical domain, review type, and meta-analysis status. Two independent reviewers will apply A Measurement Tool to Assess Systematic Reviews, version 2 (AMSTAR 2; methodological quality), PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) 2020 (reporting completeness), and, when applicable, Risk of Bias in SRs (ROBIS; risk-of-bias rigor). A preliminary AITDI will be refined and then applied to all AI-assisted SRs. Reproducibility will be assessed using SR-derived task sets to compare outputs across repeated runs of the same model, across different models, and between AI and human reviewers at key SR stages. Semistructured interviews with authors, editors, clinicians, policymakers, and patient partners will be analyzed using reflexive thematic analysis. Results: As of December 2025, the study has been preregistered on the Open Science Framework (OSF; DOI: 10.17605/OSF.IO/Q5JRW), the search strategy has been finalized, and title/abstract screening has begun. Data extraction is planned for March-May 2026, followed by AITDI refinement and reproducibility testing from May 2026 to October 2026. Qualitative interviews are anticipated from October 2026 to February 2027, with final analyses by April 2027 and dissemination planned for mid-2027. Conclusions: This study will provide one of the first empirical comparisons of methodological quality, transparency, and reproducibility of AI-assisted versus traditional SRs in the LLM era. Findings will inform expectations for responsible AI integration and support refinement of reporting and methodological best practices, including future development of AI-specific reporting and appraisal extensions (eg, PRISMA-LLM [Preferred Reporting Items for Systematic Reviews and Meta-Analyses–large language model] and AMSTAR-LLM [A Measurement Tool to Assess Systematic Reviews-large language model]).


  • Open Access

    Beyond Hemoglobin A1c—Outcomes That Matter to Individuals With Type 1 Diabetes in Adopting Digital Health Interventions for Self-Management Support: Qualitative Study

    by Benjamin Markowitz, Stephanie de Sequeira, Adhiyat Najam, Cheryl Pritlove, Dana Greenberg, Marley Greenberg, Chee-Mei Chan, Gurpreet Lakhanpal, Samyukta Jagadeesh, Geetha Mukerji, et al.

    Background: Type 1 diabetes is a demanding chronic condition that requires diligent blood glucose monitoring and timely insulin administration by patients who must integrate self-management into their daily lives. Objective: This study aimed to better understand what outcome measures are important to individuals living with type 1 diabetes (T1D) in Ontario, Canada, to help inform the development of type 1 diabetes virtual self-management Education and support (T1ME) trial. Methods: A qualitative approach was used, in which we conducted 6 focus groups with a total of 24 adult participants living with T1D (from age 18 to >65 years) in Ontario. Each focus group was semistructured in nature; participants were encouraged to talk openly about their experiences with T1D self-management and provide their perspectives on more focused topics such as technology and relationships with health care providers. Results: An interpretive analysis helped us devise a framework for our results that centered around 6 main discussion themes: (1) adapting self-management to meet evolving needs, (2) looking “beyond A1c” toward more personalized indicators of glycemic management, (3) the benefits and challenges of adopting new T1D technology, (4) establishing trusting relationships with diabetes care providers, (5) perceived benefits of peer support, and (6) pre– and post–COVID-19 perspectives on virtual care. Conclusions: Our goal is for these findings to help facilitate the development of patient-oriented outcome measures that are in line with the unique needs and preferences of T1D patients in this new, more virtual landscape of clinical care, education, and self-management support.


  • Open Access

    Patient, family and caregiver engagement in diabetes care: a scoping review protocol

    by Dita Chamoun, Mathankki Ramasamy, Carolyn Ziegler, Catherine H Yu, Pauline Wijeyesekera, Andrew Advani, Cheryl Pritlove

    Introduction New treatments and technologies have advanced diabetes care; however, diabetes continues to have a major impact on the daily lives of affected individuals, especially among equity-deserving groups. Evidence from patient engagement literature suggests that involving diverse patients in healthcare can create cost-effective improvements and enhanced efficiency in care that has high patient acceptability and numerous health benefits, as well as improved provider satisfaction. A scoping review will be conducted to provide a cohesive and comprehensive understanding of patient engagement practices and the resulting outcomes. Methods and analysis The review will follow the recommendations for the conduct of scoping reviews developed by the Joanna Briggs Institute (JBI) Scoping Review Methodology Group. The review will include English-language literature published between 1 January 1990 and the present, searched through MEDLINE (Ovid), Embase (Ovid), CINAHL (EBSCOhost), PsycINFO (Ovid), International Bibliography of the Social Sciences (IBSS), Sociological Abstracts, Applied Social Sciences Index and Abstracts (ASSIA), Scopus, Social Sciences Citation Index and Campbell Collaboration; hand searches; and grey literature. Literature that describes conceptualisations of engagement, methods/strategies for engagement and/or evaluations of engagement across different levels of diabetes care, including direct care, organisational design and governance and policymaking will be included. The review will encompass quantitative, qualitative and mixed-methods studies. Research that is secondary, published in languages other than English, or not specifically focused on patient engagement will be excluded. Screening and extraction will be completed by two independent reviewers and conflicts will be resolved by discussion or a third reviewer, with piloting at each step. Studies will be analysed through descriptive numerical summary and content analysis. Ethics and dissemination No ethical or safety considerations are pertinent to this work. The results will be disseminated to patients/patient advocacy groups, diabetes organisations, clinicians, researchers, decision-makers and policymakers by way of summary documents, infographics, meeting presentations and through peer-reviewed publications. Trial registration number The protocol has been registered with Open Science Framework: https://doi.org/10.17605/OSF.IO/KCD7Z.


  • Open Access

    “The straw that broke the camel’s back”: An analysis of racialized women clinicians’ experiences providing diabetes care

    by Arani Sivakumar, Simrit Rana, David Rofaiel, Tehmina Ahmad, Shriya Hari, Catherine H Yu

    Introduction: Racialized women clinicians (RWCs) experience the brunt of unfair racial and gendered expectations, which is a direct result of their visible identity. Our study sought to understand how these experiences intersect to impact the personal and professional well-being of RWCs, and their approach to diabetes care. Methods: Data were collected from 24 RWCs working within Canadian diabetes care settings, who participated in semi-structured, one-on-one interviews conducted from April 2021 to September 2021. The data were qualitatively analyzed using thematic analysis to develop emergent themes, and interactions were explored using the socioecological model (SEM), adapted to our study context. Results: We identified three themes: (1) Discordance between self-identity and relational identity impacted how RWCs interacted with others, and how others interacted with them; (2) Tokenistic, “inclusive” organizational policies/practices and inherently racist and sexist social norms permitted acts of discrimination and led to the systematic othering and exclusion of RWCs within the workplace; and (3) Differential treatment of RWCs had both positive and negative impacts on participants’ relational, workplace and self-identity. Using the SEM, we also found that differential treatment of RWCs stems from upstream policies, structures, and social norms, percolating through different levels of the SEM, including work environments and communities, which eventually impacts one’s relational identity, as well as one’s perception of oneself. Conclusion: The differential treatment of RWCs arises predominantly from macro systems of the work environment. The burden to address these disparities must be shifted to the source (i.e., namely systems) by implementing interventions that equitably value diversity efforts, institute policies of accountability and correction of implicit biases, and prioritize an inclusive culture broadly across faculty and leadership.


  • Open Access

    Optimizing a mentorship program from the perspective of academic medicine leadership – a qualitative study

    by Michael Ren, Dorothy Choi, Chloe Chan, Simrit Rana, Umberin Najeeb, Mireille Norris, Simron Singh, Karen E. A. Burns, Sharon E. Straus, Gillian Hawker, et al.

    Effective mentorship is an important contributor to academic success. Given the critical role of leadership in fostering mentorship, this study sought to explore the perspectives of departmental leadership regarding 1) current departmental mentorship processes; and 2) crucial components of a mentorship program that would enhance the effectiveness of mentorship. Department Division Directors (DDDs), Vice-Chairs, and Mentorship Facilitators from the Department of Medicine at the University of Toronto Temerty Faculty of Medicine were interviewed between April and December 2021 using a semi-structured guide. Interviews were audio-recorded and transcribed verbatim, then coded. Analysis occurred in 2 steps: 1) codes were organized to identify emergent themes; then 2) the Social Ecological Model (SEM) was applied to interpret the findings. Nineteen interviews (14 DDDs, 3 Vice-Chairs, and 2 Mentorship Facilitator) were completed. Analysis revealed three themes: (1) a culture of mentorship permeated the department as evidenced by rigorous mentorship processes, divisional mentorship innovations, and faculty that were keen to mentor; (2) barriers to the establishment of effective mentoring relationships existed at 3 levels: departmental, interpersonal (mentee-mentor relationships), and mentee; and (3) strengthening the culture of mentorship could entail scaling up pre-existing mentorship processes and promoting faculty engagement. Application of SEM highlighted critical program features and determined that two components of interventions (creating tools to measure mentorship outcomes and systems for mentor recognition) were potential enablers of success. Establishing ‘mentorship outcome measures’ can incentivize and maintain relationships. By tangibly delineating departmental expectations for mentorship and creating systems that recognize mentors, these measures can contribute to a culture of mentorship.


  • Open Access

    Beyond Hemoglobin A1c—Outcomes That Matter to Individuals With Type 1 Diabetes in Adopting Digital Health Interventions for Self-Management Support: Qualitative Study (Preprint)

    by Benjamin Markowitz, Stephanie de Sequeira, Adhiyat Najam, Cheryl Pritlove, Dana Greenberg, Marley Greenberg, Chee-Mei Chan, Gurpreet Lakhanpal, Samyukta Jagadeesh, Geetha Mukerji, et al.

    BACKGROUND Type 1 diabetes is a demanding chronic condition that requires diligent blood glucose monitoring and timely insulin administration by patients who must integrate self-management into their daily lives. OBJECTIVE This study aimed to better understand what outcome measures are important to individuals living with type 1 diabetes (T1D) in Ontario, Canada, to help inform the development of type 1 diabetes virtual self-management Education and support (T1ME) trial. METHODS A qualitative approach was used, in which we conducted 6 focus groups with a total of 24 adult participants living with T1D (from age 18 to >65 years) in Ontario. Each focus group was semistructured in nature; participants were encouraged to talk openly about their experiences with T1D self-management and provide their perspectives on more focused topics such as technology and relationships with health care providers. RESULTS An interpretive analysis helped us devise a framework for our results that centered around 6 main discussion themes: (1) adapting self-management to meet evolving needs, (2) looking “beyond A1c” toward more personalized indicators of glycemic management, (3) the benefits and challenges of adopting new T1D technology, (4) establishing trusting relationships with diabetes care providers, (5) perceived benefits of peer support, and (6) pre– and post–COVID-19 perspectives on virtual care. CONCLUSIONS Our goal is for these findings to help facilitate the development of patient-oriented outcome measures that are in line with the unique needs and preferences of T1D patients in this new, more virtual landscape of clinical care, education, and self-management support. CLINICALTRIAL

  • Open Access

    Prolactinoma and Adenomyosis – More than Meets the Eye: A Case Report

    by Shereen Khattab, Catherine H. Yu, Sapna Shah